Acifran

PrEST Antigen AGPAT2 1-acylglycerol-3-phosphate O-acyltransf

PrEST Antigen AGPAT5 1-acylglycerol-3-phosphate O-acyltransf

PrEST Antigen AGPAT5 1-acylglycerol-3-phosphate O-acyltransf

Product Describtion:Pyripyropene A is a potent and selective sterol O-acyltransferase 2 (SOAT2)/acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) inhibitor, with an IC50 of 0.07 µM. Pyripyropene A attenuates hypercholesterolemia and

Product Describtion:Pyripyropene A is a potent and selective sterol O-acyltransferase 2 (SOAT2)/acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) inhibitor, with an IC50 of 0.07 µM. Pyripyropene A attenuates hypercholesterolemia and

Purity: &gt:95%, by SDS-PAGE visualized with Coomassie® Blue Staining.Description:Fatty Acid Synthase (FASN) is a multifunctional enzyme crucial for the de novo biosynthesis of long-chain saturated fatty acids, utilizing acetyl-CoA and malonyl-CoA

Purity: &gt:95%, by SDS-PAGE visualized with Coomassie® Blue Staining.Description:Fatty Acid Synthase (FASN) is a multifunctional enzyme crucial for the de novo biosynthesis of long-chain saturated fatty acids, utilizing acetyl-CoA and malonyl-CoA

Purity: &gt:95%, by SDS-PAGE visualized with Coomassie® Blue Staining.Description:Fatty Acid Synthase (FASN) is a multifunctional enzyme crucial for the de novo biosynthesis of long-chain saturated fatty acids, utilizing acetyl-CoA and malonyl-CoA

InformationRimonabant (SR141716) is a selective antagonist ofCB1withIC50of 13.6 nM andEC50of 17.3 nM in hCB1 transfected HEK 293 membrane. Rimonabant is also a dual inhibitor ofacyl CoA:cholesterol acyltransferases(ACAT) 1 and 2and inhibits

InformationRP-64477 RP-64477 is a potent inhibitor of the cholesterol esterifying enzyme Acyl-coenzyme A:cholesterol O-acyltransferase (ACAT) . RP-64477 inhibits ACAT activity with IC50 of 113 nM, 503 nM, and 180 nM in human intestinal (CaCo-2),

An inhibitor of long fatty acid acyl-CoA synthetase (IC50 = 6.3 &muM in Raji cells) that interferes with lipid metabolism by inhibiting the de novo synthesis of triglycerides, diglycerides, and cholesterol esters acts as a hypotensive vasodilator.

An inhibitor of long fatty acid acyl-CoA synthetase (IC50 = 6.3 &muM in Raji cells) that interferes with lipid metabolism by inhibiting the de novo synthesis of triglycerides, diglycerides, and cholesterol esters acts as a hypotensive vasodilator.